Risk Factors for Neck Phlegmon After Percutaneous Tracheostomy in ICU

What this Trial Is About

Researchers are studying patients admitted to intensive care who undergo percutaneous tracheostomy to understand the risk factors leading to the development of neck phlegmon, a possible complication after this procedure. The study aims to see how this complication affects hospital stay length, mortality, and quality of life over time. This observational study is sponsored by Azienda Usl di Bologna and focuses on health outcomes related to tracheostomy complications. Participants receive a percutaneous tracheostomy, a procedure that creates a direct airway passage in the neck by placing a cannula through the trachea. The study observes patients receiving this procedure for any reason during their ICU stay. There is no treatment assigned by the study; instead, researchers monitor outcomes following the procedure. Participants are followed for 7 days after the tracheostomy to detect any neck phlegmon formation. Additional follow-ups occur up to two years to assess health-related quality of life and symptoms such as swallowing difficulties, voice problems, breathing issues, and cough. Researchers also track intensive care and hospital stays, as well as mortality within 30 days. The total participation duration includes immediate post-procedure monitoring and long-term health assessments.

riSk Factors fOR neCk phlEgmon afteR pErcutaneous tRacheostomy in ICU